Jose Yuste

Profesor

Universidad de Navarra

Spain

Research Interests

Explore related searches

Professors in Spain Professors in Immunology Immunology professors in Spain

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Jose Yuste is a Professor at Universidad de Navarra in Spain. His research focuses on infectious diseases, pathophysiology, and clinical microbiology as evidenced by his recent articles on bacterial identification methods, the role of adrenomedullin in infections, and the impact of antibiotic stewardship programs. His work also explores the implications of COVID-19 on immune responses and organ health.

Articles (14)

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Collaborators (15)

Roberto Cangemi

Associate Professor

Università degli Studi di Roma La Sapienza

ITALY

Jose Yuste

Research Interests

Explore related searches

Contact this professor

About

Articles (14)

A Focus on the Pathophysiology of Adrenomedullin Expression: Endothelitis and Organ Damage in Severe Viral and Bacterial Infections

Accelerated Bacterial Identification with MALDI-TOF MS Leads to Fewer Diagnostic Tests and Cost Savings

Mid-Regional Pro-Adrenomedullin Can Predict Organ Failure and Prognosis in Sepsis?

Clinical Impact of Rapid Bacterial Microbiological Identification with the MALDI-TOF MS

Immunoguided Discontinuation of Prophylaxis for Cytomegalovirus Disease in Kidney Transplant Recipients Treated With Antithymocyte Globulin: A Randomized Clinical Trial.

Impact of Infectious Diseases training in the perception of antibiotic resistance and rational use of antibiotics among Spanish medical students – a cross-sectional study

C5a elevation in convalescents from severe COVID-19 is not associated with early complement activation markers C3bBbP or C4d

Impact of the Acceptance of the Recommendations Made by a Meropenem Stewardship Program in a University Hospital: A Pilot Study

Therapeutic versus Prophylactic Bemiparin in Hospitalized Patients with Nonsevere COVID-19 Pneumonia (BEMICOP Study): An Open-Label, Multicenter, Randomized, Controlled Trial

Persistence of High Levels of Serum Complement C5a in Severe COVID-19 Cases After Hospital Discharge.

A multicenter randomized open-label clinical trial for convalescent plasma in patients hospitalized with COVID-19 pneumonia

Immunological Biomarkers of Fatal COVID-19: A Study of 868 Patients

Pretransplant CMV-Specific T-Cell Immunity But Not Dose of Antithymocyte Globulin Is Associated With Recovery of Specific Immunity After Kidney Transplantation.

The effect of early treatment with ivermectin on viral load, symptoms and humoral response in patients with non-severe COVID-19: A pilot, double-blind, placebo-controlled, randomized clinical trial.

Collaborators (15)

Roberto Cangemi

massimo ciccozzi

JAIME PEREZ DE OTEYZA

Ruben Pio

silvia spoto

Antonio F Caballero Bermejo

Isabel Salcedo de Diego

Cristina Pérez Ruiz

María Marcos Jubilar

José Santiago Sánchez Sosa

Josepmaria Argemi

Domingo Jerónimo Hernández Marrero

M Teresa Pérez-Warnisher

Alberto Rodríguez Benot

Daniel Ajona

Make your next move.